Skip to content

MAZE MAZE Investing Cash Flow

Investing Cash Flow at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$431.9M-674%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$23.82M-389%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$50.69M+272%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.53M+110%
Zymeworks logo
ZymeworksZYME
$69.96M+474%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$123.83M-585%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's investing cash flow?
MAZE (MAZE) reported investing cash flow of $6.28M in Q1 2026.
How has MAZE's investing cash flow changed year-over-year?
MAZE's investing cash flow increased by 2198.7% year-over-year, from -$299K to $6.28M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.